Cumberland Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Cumberland Pharmaceuticals's estimated annual revenue is currently $37.9M per year.
- Cumberland Pharmaceuticals's estimated revenue per employee is $499,079
- Cumberland Pharmaceuticals's current valuation is $55.6M. (January 2022)
Employee Data
- Cumberland Pharmaceuticals has 76 Employees.
- Cumberland Pharmaceuticals grew their employee count by 52% last year.
Cumberland Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Organizational Development | Reveal Email/Phone |
2 | EVP, Operations & Chief Development Officer | Reveal Email/Phone |
3 | Managing Director | Reveal Email/Phone |
4 | Director, Field Sales | Reveal Email/Phone |
5 | Associate Director, Regulatory Affairs | Reveal Email/Phone |
6 | Director National Accounts | Reveal Email/Phone |
7 | Assistant Product Manager | Reveal Email/Phone |
8 | Executive Regional Business Manager | Reveal Email/Phone |
9 | Assistant Product Manager | Reveal Email/Phone |
10 | Pharmacovigilance and Medical Information, Manager | Reveal Email/Phone |
Cumberland Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $145.5M | 517 | 0% | $28.5M | N/A |
#2 | $102.7M | 511 | 7% | N/A | N/A |
#3 | $58.7M | 292 | 1% | N/A | N/A |
#4 | $8.2M | 41 | -2% | N/A | N/A |
#5 | $22.5M | 112 | 12% | $23.6M | N/A |
#6 | $5.6M | 28 | 4% | N/A | N/A |
#7 | $11.3M | 56 | 8% | N/A | N/A |
#8 | $13.1M | 65 | 7% | N/A | N/A |
#9 | $7.6M | 38 | 15% | N/A | N/A |
#10 | $7.2M | 36 | 3% | N/A | N/A |
What Is Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals Inc. (http://www.cumberlandpharma.com/) is a Tennessee-based specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. Cumberland's primary target markets include hospital acute care and gastroenterology. Cumberland markets Acetadote(R) for the treatment of acetaminophen poisoning and Kristalose(R), a prescription strength laxative. The Company is also developing Amelior(R) which is in Phase III studies for the treatment of both pain and fever. Cumberland is dedicated to providing innovative products which improve quality of care for patients.
keywords:N/A
N/A
Total Funding
76
Number of Employees
$37.9M
Revenue (est)
52%
Employee Growth %
$55.6M
Valuation
N/A
Accelerator
Cumberland Pharmaceuticals News
The brokerage set a hold rating on the specialty pharmaceutical company's stock. Separately, TheStreet cut shares of Cumberland...
Morgan Stanley raised its position in Cumberland Pharmaceuticals by 131.3% during the first quarter. Morgan Stanley now owns 11,160 shares of...
Tabuk Pharmaceutical Manufacturing Co., a unit of Astra Industrial Group, reached an agreement with Cumberland for rights to the drug in Saudi...
NASHVILLE, Tenn., Aug. 10, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and second quarter 2021 financial results. Net revenues from continuing operations during the quarter were $9.1 million and to ...
NASHVILLE, Tenn., Aug. 10, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and second quarter 2021 financial results. Net revenues from continuing operations during the quarter were $9.1 million and tota ...
Other Companies in Nashville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13.1M | 76 | N/A | N/A |
#2 | $15M | 76 | -27% | N/A |
#3 | $20.5M | 76 | 9% | N/A |
#4 | $11M | 76 | 38% | N/A |
#5 | $22.8M | 76 | 7% | N/A |